Archives of Physiology and Biochemistry,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 9
Published: Nov. 14, 2024
The
impact
of
triglyceride
levels
is
important
to
understand
the
changes
in
metabolism
and
structure.
With
an
increase
obesity
hyperlipidemia
due
diet;
cardiovascular
neuronal
structural
have
been
shown
be
more
distinct.
Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(7), P. 768 - 768
Published: June 26, 2024
Metabolic
syndrome
(MetS)
is
a
multifactorial
condition
that
significantly
increases
the
risk
of
cardiovascular
disease
and
chronic
kidney
(CKD).
Recent
studies
have
emphasized
role
lipid
dysregulation
in
activating
cellular
mechanisms
contribute
to
CKD
progression
context
MetS.
Sodium-glucose
cotransporter
2
inhibitors
(SGLT2i)
demonstrated
efficacy
improving
various
components
MetS,
including
obesity,
dyslipidemia,
insulin
resistance.
While
SGLT2i
shown
cardioprotective
benefits,
underlying
MetS
remain
poorly
studied.
Therefore,
this
review
aims
elucidate
by
which
modulate
metabolism
their
impact
on
resistance,
mitochondrial
dysfunction,
oxidative
stress,
progression.
We
also
explore
potential
benefits
combining
with
other
antidiabetic
drugs.
By
examining
beneficial
effects,
molecular
targets,
cytoprotective
both
natural
synthetic
SGLT2i,
provides
comprehensive
understanding
therapeutic
managing
MetS-induced
CKD.
The
information
presented
here
highlights
significance
addressing
complex
interplay
between
metabolic
dysregulation,
renal
impairment,
offering
clinicians
researchers
valuable
resource
for
developing
improved
treatment
strategies
personalized
approaches
patients
Phytomedicine,
Journal Year:
2025,
Volume and Issue:
140, P. 156582 - 156582
Published: Feb. 26, 2025
The
clinical
application
of
cyclosporine
A
(CsA)
is
limited
due
to
nephrotoxicity.
Lipid
metabolism
disorders
play
important
roles
in
renal
injury,
but
their
role
CsA
nephrotoxicity
not
yet
clear.
Huangqi
(Astragalus
mongholicus
Bunge)
and
Danshen
(Salvia
miltiorrhiza
(HD)
ameliorating
the
CsA,
mechanisms
still
need
be
fully
clarified.
This
study
innovatively
aimed
analyse
coexpression
proteins
serum
metabolites
for
identification
key
pathways
targets.
provides
novel
insight
into
mechanism
by
which
HD
ameliorates
CsA-induced
We
utilized
intervene
both
vivo
vitro
models
induced
CsA.
For
experiments,
we
constructed
a
network
metabolites,
was
used
screen
pathways.
To
validate
these
findings,
knocked
down
vivo.
studies,
employed
MTT,
Transwell,
flow
cytometry,
immunofluorescence
assays
monitor
epithelial-mesenchymal
transition
(EMT)
HK-2
cells.
Additionally,
electron
microscopy
Seahorse
examine
effects
on
mitochondrial
structure
function.
Furthermore,
overexpressed
Ppara
further
confirm
improves
can
improve
pathological
damage
function;
regulate
blood
lipids,
inflammation
oxidative
stress
indicators;
reduce
apoptosis
tissues.
Joint
protein
metabolomics
analyses
revealed
that
two
lipid
metabolism-related
(the
PPAR
signalling
pathway
linoleic
acid
pathway)
were
coenriched,
involving
six
differential
(Cyp2e1,
Cyp4a10,
Gk,
Lpl,
Ppara,
Pck1)
differentially
abundant
(alpha-Dimorphecolic
12,13-EpOME).
Western
blot
verify
expressed
proteins.
improved
accumulation,
as
demonstrated
transmission
(TEM)
analysis
Oil
Red
O
staining.
Knockdown
affected
expression
ACOX1
exacerbated
RF.
In
verification
significantly
inhibited
EMT
cells
overexpression
promoted
HD-mediated
regulation
function,
reduced
apoptosis,
ameliorate
through
protein-serum
coexpression,
pathway,
metabolism.
HD-induced
upregulation
metabolism,
function
are
mechanisms.
Ppara/ACOX1/TGF-β1
axis
may
an
this
process.
These
findings
offer
potential
targets
future
development
therapeutic
strategies
drugs.
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(6), P. 1827 - 1827
Published: March 8, 2025
Background:
Familial
chylomicronemia
syndrome
(FCS)
is
a
rare
autosomal
recessive
disorder
characterized
by
extreme
hypertriglyceridemia
(>1000
mg/dL),
recurrent
pancreatitis,
and
lipoprotein
lipase
(LPL)
deficiency.
Mutations
in
the
LMF1
gene,
encoding
chaperone
protein
required
for
LPL
maturation,
can
lead
to
combined
This
study
reports
case
of
33-year-old
Ecuadorian
mestizo
woman
presenting
with
pancreatitis
secondary
severe
hypertriglyceridemia,
whom
two
variants
uncertain
significance
(VUS)
were
identified.
Methods:
Whole-exome
sequencing
(WES)
was
performed
on
patient
her
asymptomatic
son
using
next-generation
(NGS).
Data
analysis
included
computational
pathogenicity
predictors
(REVEL,
PolyPhen,
SIFT,
MutationTaster,
etc.).
Two
variants—c.1142C>T
(p.Pro381Leu)
c.897G>A
(p.Gln299Gln)—were
Their
pathogenic
potential
assessed
based
allele
frequency
(gnomAD),
bioinformatics
predictions,
ACMG
criteria.
Results:
Both
classified
as
VUS,
predicted
affect
splicing,
potentially
leading
loss
function.
The
c.1142C>T
variant,
despite
its
low
frequency,
remains
unclassified
due
insufficient
evidence.
patient’s
carried
one
variant
but
asymptomatic.
phenotype
suggested
an
intermediate
form
between
monogenic
polygenic
hypertriglyceridemia.
Conclusions:
new
report
LMF1-related
highlighting
need
functional
studies
confirm
pathogenicity.
Given
classification
both
further
research
elucidate
their
clinical
significance.
underscores
necessity
genetic
biochemical
approach
diagnosing
managing
Proceedings of the National Academy of Sciences,
Journal Year:
2025,
Volume and Issue:
122(12)
Published: March 20, 2025
Lipoprotein
lipase
(LPL)
carries
out
the
lipolytic
processing
of
triglyceride-rich
lipoproteins
(TRL)
along
luminal
surface
capillaries.
LPL
activity
is
regulated
by
angiopoietin-like
proteins
(ANGPTL3,
ANGPTL4,
ANGPTL8),
which
control
delivery
TRL-derived
lipid
nutrients
to
tissues
in
a
temporal
and
spatial
fashion.
This
regulation
mediates
partitioning
adipose
tissue
striated
muscle
according
nutritional
status.
A
complex
between
ANGPTL3
ANGPTL8
(ANGPTL3/8)
inhibits
oxidative
tissues,
but
its
mode
action
has
remained
unknown.
Here,
we
used
biophysical
techniques
define
how
ANGPTL3/8
interact
with
they
drive
inactivation.
We
demonstrate,
mass
photometry,
that
heterotrimer
2:1
ANGPTL3:ANGPTL8
stoichiometry
homotrimer.
Hydrogen–deuterium
exchange
spectrometry
(HDX-MS)
studies
revealed
use
proximal
portion
their
N-terminal
α-helices
sequences
surrounding
catalytic
pocket
LPL.
That
binding
event
triggers
unfolding
LPL’s
α/β
-hydrolase
domain
irreversible
loss
activity.
The
endothelial
transporter
protein
(GPIHBP1)
or
heparan-sulfate
proteoglycans
protects
from
inactivation,
particularly
against
triggered
ANGPTL3.
Pulse-labeling
HDX-MS
catalyze
an
ATP-independent
fashion,
categorizes
these
inhibitors
as
atypical
unfoldases.
nature
explains
why
low
plasma
concentrations
are
effective
inhibiting
molar
excess
Cancer Communications,
Journal Year:
2024,
Volume and Issue:
44(8), P. 855 - 878
Published: July 3, 2024
Abstract
Background
Lymph
node
metastasis
(LNM)
is
the
primary
mode
of
in
gastric
cancer
(GC).
However,
precise
mechanisms
underlying
this
process
remain
elusive.
Tumor
cells
necessitate
lipid
metabolic
reprogramming
to
facilitate
metastasis,
yet
role
lipoprotein
lipase
(LPL),
a
pivotal
enzyme
involved
exogenous
uptake,
remains
uncertain
tumor
metastasis.
Therefore,
aim
study
was
investigate
presence
during
LNM
GC
as
well
LPL
process.
Methods
Intracellular
levels
were
quantified
using
oil
red
O
staining,
BODIPY
493/503
and
flow
cytometry.
Lipidomics
analysis
employed
identify
alterations
intracellular
composition
following
knockdown.
Protein
expression
assessed
through
immunohistochemistry,
Western
blotting,
enzyme‐linked
immunosorbent
assays.
The
mouse
popliteal
model
utilized
differences
LNM.
Immunoprecipitation
mass
spectrometry
examine
protein
associations.
In
vitro
phosphorylation
assays
Phos‐tag
sodium
dodecyl‐sulfate
polyacrylamide
gel
electrophoresis
conducted
detect
angiopoietin‐like
4
(ANGPTL4)
phosphorylation.
Results
We
identified
that
an
elevated
level
represents
crucial
characteristic
node‐positive
(N+)
further
demonstrated
high‐fat
diet
can
expedite
found
be
significantly
overexpressed
N+
tissues
shown
by
mediating
dietary
uptake
within
cells.
Leptin,
obesity‐related
hormone,
intercepted
effect
exerted
ANGPTL4/Furin
on
cleavage.
Circulating
leptin
binding
receptor
could
induce
activation
inositol‐requiring
enzyme‐1
(IRE1)
kinase,
leading
ANGPTL4
at
serine
30
residue
subsequently
reducing
its
affinity
with
LPL.
Moreover,
our
research
revealed
disrupted
homeostasis
elevating
arachidonic
acid,
which
then
triggered
cyclooxygenase‐2/prostaglandin
E2
(PGE2)
pathway,
thereby
promoting
lymphangiogenesis.
Conclusions
Leptin‐induced
facilitates
LPL‐mediated
consequently
stimulates
production
PGE2,
ultimately
facilitating
GC.
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(17), P. 5229 - 5229
Published: Sept. 4, 2024
Over
50%
of
patients
who
take
statins
are
still
at
risk
developing
atherosclerotic
cardiovascular
disease
(ASCVD)
and
do
not
achieve
their
goal
LDL-C
levels.
This
residual
is
largely
dependent
on
triglyceride-rich
lipoproteins
(TRL)
remnants.
In
essence,
remnant
cholesterol-rich
chylomicron
(CM)
very-low-density
lipoprotein
(VLDL)
particles
play
a
role
in
atherogenesis.
These
remnants
increase
when
lipase
(LPL)
activity
inhibited.
ApoCIII
has
been
thoroughly
studied
as
chief
inhibitor
therapeutic
options
to
curb
its
effect
available.
On
top
apoCIII
regulation
LPL
activity,
there
more
precise
control
various
tissues,
which
makes
it
easier
physiologically
divide
the
TRL
burden
according
body’s
requirements.
general,
oxidative
tissues
such
skeletal
cardiac
muscle
preferentially
up
lipids
during
fasting.
Conversely,
adipocytes
increases
significantly
after
feeding,
while
decreases
concurrently.
perspective
addresses
recent
improvements
our
understanding
circadian
regulations
implications.
Three
major
tissue-specific
lipolysis
regulators
have
identified:
ANGPTL3,
ANGPTL4,
ANGPTL8.
Briefly,
postprandial
phase,
liver
ANGPTL8
acts
ANGPTL3
(which
released
continuously
from
liver)
inhibit
heart
through
an
endocrine
mechanism.
other
hand,
fasting,
by
adipocytes,
inhibits
adipose
tissue
paracrine
manner.
inhibitors
may
treatment
hypertriglyceridemia.
Several
approaches
under
development.
We
look
forward
future
studies
clarify
(a)
nature
hormonal
nutritional
factors
that
determine
4,
8
activities,
along
with
what
long-term
impacts
be
expected
if
impaired
pharmacologically;
(b)
quantitative
hierarchy
interaction
regulatory
actions
apoCIII,
apoAV,
ANGPTL
activity;
(c)
strategies
for
safe
proper
lipemia;
(d)
fructose
restriction